Rahsaan Thompson insider trades: Zevra Therapeutics (ZVRA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Rahsaan reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | ZVRA | ↓ Sell | 42,666 | $11.13 | $475K | Direct | Aug 17, 2026 (3d) |
| Jun 22, 2026 | ZVRA | ↓ Sell | 34,557 | $12.68 | $438K | Direct | Jun 23, 2026 (1d) |
| May 11, 2026 | ZVRA | ↓ Sell | 1,794 | $11.30 | $20K | Direct | May 13, 2026 (2d) |
| Jun 26, 2025 | ZVRA | ↓ Sell | 24,000 | $9.21 | $221K | Direct | Jun 30, 2025 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ZVRA insiders
Open-market trades in the last 12 months
About Rahsaan Thompson's insider trades
Rahsaan Thompson is Chief Legal & Compliance at Zevra Therapeutics (ZVRA). Since Jun 26, 2025, Rahsaan has reported no open-market purchases and 4 sales worth $1.2M on SEC Form 4. In the last 12 months: 3 sales ($933K).
Their filings also include grants and awards (8 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ZVRA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.